MTHFR, TYMS and SLCO1B1 polymorphisms and adverse liver effects of methotrexate in rheumatoid arthritis
Pharmacogenomics, Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - February 6, 2020 Category: Genetics & Stem Cells Authors: Johanna Karlsson Sundbaum Eva Baecklund Niclas Eriksson P är Hallberg Hugo Kohnke Mia Wadelius Source Type: research

Genetics and treatment of gastrointestinal stromal tumors with immune checkpoint inhibitors: what do we know?
Pharmacogenomics, Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - January 24, 2020 Category: Genetics & Stem Cells Authors: Valentina Indio Annalisa Astolfi Milena Urbini Margherita Nannini Maria A Pantaleo Source Type: research

Prioritizing rs7294 as a mirSNP contributing to warfarin dosing variability
Pharmacogenomics, Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - January 24, 2020 Category: Genetics & Stem Cells Authors: Linda Koshy S Harikrishnan PR Sudhakaran Source Type: research

PARP inhibitors: a tsunami of indications in different malignancies
Pharmacogenomics,Volume 21, Issue 3, Page 221-230, February 2020. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - January 22, 2020 Category: Genetics & Stem Cells Authors: Ga ëlle Haddad Marie Christelle Saad é Roland Eid Fady Gh Haddad Hampig Raphael Kourie Source Type: research

Evaluation of clinical impact of pharmacogenomics knowledge involved in CPIC guidelines on Chinese pediatric patients
Pharmacogenomics,Volume 21, Issue 3, Page 209-219, February 2020. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - January 22, 2020 Category: Genetics & Stem Cells Authors: Weifeng Qin Zhenglin Du Jingfa Xiao Huilong Duan Qiang Shu Haomin Li Source Type: research

microRNA-137 downregulates MCL1 in ovarian cancer cells and mediates cisplatin-induced apoptosis
Pharmacogenomics,Volume 21, Issue 3, Page 195-207, February 2020. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - January 22, 2020 Category: Genetics & Stem Cells Authors: Wei Chen Jingjie Du Xiaodi Li Ziming Zhi Songshan Jiang Source Type: research

OPRM1 and COMT polymorphisms: implications on postoperative acute, chronic and experimental pain after cardiac surgery
Pharmacogenomics,Volume 21, Issue 3, Page 181-193, February 2020. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - January 22, 2020 Category: Genetics & Stem Cells Authors: Maja Matic Sjoerd de Hoogd Saskia N de Wildt Dick Tibboel Catherijne AJ Knibbe Ron HN van Schaik Source Type: research

Pharmacogenetics and pharmacokinetics modeling of unexpected and extremely severe toxicities after sorafenib intake
Pharmacogenomics,Volume 21, Issue 3, Page 173-179, February 2020. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - January 22, 2020 Category: Genetics & Stem Cells Authors: Hai le Ba Litaty Mbatchi Florence Gattacceca Alexandre Evrard Bruno Lacarelle Benoit Blanchet Joseph Ciccolini S ébastien Salas Source Type: research

Association between rs4149056 variant in SLCO1B1 and early discontinuation of statin after acute myocardial infarction
Pharmacogenomics,Volume 21, Issue 3, Page 163-172, February 2020. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - January 22, 2020 Category: Genetics & Stem Cells Authors: Abdallah Al-Salameh Nicolas Danchin C éline Verstuyft Salma Kotti Etienne Puymirat Jean Ferri ères Fran çois Schiele Pierre Coste Gilles Lemesle Guillaume Cayla Laurent Becquemont Tabassome Simon Source Type: research

Gene signatures of breast cancer development and the potential for novel targeted treatments
Pharmacogenomics,Volume 21, Issue 3, Page 157-161, February 2020. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - January 22, 2020 Category: Genetics & Stem Cells Authors: Charu Kothari Caroline Diorio Francine Durocher Source Type: research

The emergent phenomenon of aspirin resistance: insights from genetic association studies
Pharmacogenomics,Volume 21, Issue 2, Page 125-140, January 2020. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - January 20, 2020 Category: Genetics & Stem Cells Authors: M árcia Ferreira Margarida Freitas-Silva Joana Assis Ricardo Pinto Jos é P Nunes Rui Medeiros Source Type: research

Effects of CYP2C19*2 polymorphisms on the efficacy and safety of phenazepam in patients with anxiety disorder and comorbid alcohol use disorder
Pharmacogenomics,Volume 21, Issue 2, Page 111-123, January 2020. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - January 20, 2020 Category: Genetics & Stem Cells Authors: Michael S Zastrozhin Valentin Y Skryabin Marco Torrado Anastasiya Petrovna Alexander S Sorokin Elena A Grishina Kristina A Ryzhikova Inessa A Bedina Oleg Z Buzik Egor M Chumakov Ludmila M Savchenko Evgeny A Brun Dmitry A Sychev Source Type: research

Genotype-guided treatment of oral P2Y12 inhibitors: where do we stand?
Pharmacogenomics,Volume 21, Issue 2, Page 83-86, January 2020. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - January 20, 2020 Category: Genetics & Stem Cells Authors: Daniel MF Claassens Jurri ën M ten Berg Source Type: research

Pharmacogenomics at the center of precision medicine: challenges and perspective in an era of Big Data
Pharmacogenomics, Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - January 17, 2020 Category: Genetics & Stem Cells Authors: Dragan Primorac Lidija Bach-Rojecky Dalia Va đunec Alen Juginovi ć Katarina Žunić Vid Mati šić Andrea Skelin Borna Arsov Luka Boban Damir Erceg Ivana Erceg Ivko šić Vilim Molnar Jasmina Ćatić Ivan Mikula Ljubica Boban Lara Primorac Bernard Esqui Source Type: research

Untangling the genetic basis of drug response
Pharmacogenomics, Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 19, 2019 Category: Genetics & Stem Cells Authors: Palle Duun Rohde Torsten Nygaard Kristensen Source Type: research

Impact of CYP2C9, VKORC1, ApoE and ABCB1 polymorphisms on stable warfarin dose requirements in elderly Chinese patients
Pharmacogenomics, Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 19, 2019 Category: Genetics & Stem Cells Authors: Wenyan Li Ping Zhao Liwen Chen Xiaoyin Lai Guohua Shi Longxuan Li Jing Dong Source Type: research

A potential role for the CDH13/CDH15 gene in repeat revascularization after first percutaneous coronary intervention
Pharmacogenomics, Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 19, 2019 Category: Genetics & Stem Cells Authors: Qian Xiang Zhiyan Liu Yun Lu Jie Mao Shuqing Chen Xun Zhao Shuang Zhou Qiufen Xie Zining Wang Guangyan Mu Jie Jiang Yanjun Gong Yimin Cui Source Type: research

Germline variants and response to systemic therapy in advanced prostate cancer
Pharmacogenomics,Volume 21, Issue 1, Page 75-81, January 2020. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 18, 2019 Category: Genetics & Stem Cells Authors: Eric Johnson Roberto Nussenzveig Neeraj Agarwal Umang Swami Source Type: research

Personalized pediatric anesthesia and pain management: problem-based review
Pharmacogenomics,Volume 21, Issue 1, Page 55-73, January 2020. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 18, 2019 Category: Genetics & Stem Cells Authors: Senthil Packiasabapathy Valluvan Rangasamy Nicole Horn Michele Hendrickson Janelle Renschler Senthilkumar Sadhasivam Source Type: research

Cost –effectiveness of CYP2C19 LOF-guided antiplatelet therapy in Chinese patients with acute coronary syndrome
Pharmacogenomics,Volume 21, Issue 1, Page 33-42, January 2020. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 18, 2019 Category: Genetics & Stem Cells Authors: Yu Fu Xin-yi Zhang Si-bei Qin Xiao-yan Nie Lu-wen Shi Hong Shao Jian Liu Source Type: research

Comparison of the prediction performance of different warfarin dosing algorithms based on Chinese patients
Pharmacogenomics,Volume 21, Issue 1, Page 23-32, January 2020. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 18, 2019 Category: Genetics & Stem Cells Authors: Cheng Xie Ling Xue Yuzhen Zhang Jianguo Zhu Ling Zhou Yongfu Hang Xiaoliang Ding Bin Jiang Liyan Miao Source Type: research

CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy
Pharmacogenomics,Volume 21, Issue 1, Page 7-21, January 2020. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 18, 2019 Category: Genetics & Stem Cells Authors: Fabiana Dalla Vecchia Genvigir Antony Brayan Campos-Salazar Claudia Rosso Felipe Helio Tedesco-Silva Jos é Osmar Medina-Pestana Sonia de Quateli Doi Alvaro Cerda Mario Hiroyuki Hirata Mar ía José Herrero Salvador Francisco Ali ño Rosario Dominguez Cre Source Type: research

Pharmacogenetics of methotrexate response in rheumatoid arthritis: an update
Pharmacogenomics,Volume 21, Issue 1, Page 3-6, January 2020. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 18, 2019 Category: Genetics & Stem Cells Authors: Stephanie F Ling James Bluett Source Type: research

Pharmacogenomics foreword 2020
Pharmacogenomics,Volume 21, Issue 1, Page 1-1, January 2020. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 18, 2019 Category: Genetics & Stem Cells Authors: Sarah Jones Source Type: research

Circulating tumor DNA (ctDNA) in precision oncology of ovarian cancer
Pharmacogenomics,Volume 20, Issue 18, Page 1251-1253, December 2019. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 1, 2019 Category: Genetics & Stem Cells Authors: Jaana Oikkonen Sampsa Hautaniemi Source Type: research

Effects of pharmacogenetic variants on vemurafenib-related toxicities in patients with melanoma
Pharmacogenomics,Volume 20, Issue 18, Page 1283-1290, December 2019. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 1, 2019 Category: Genetics & Stem Cells Authors: Andrew KL Goey Mirjam de With Bram C Agema Esther Oomen-De Hoop Rajbir K Singh Astrid AM van der Veldt Ron HJ Mathijssen Ron HN van Schaik Sander Bins Source Type: research

Circulating tumor DNA and the future of EGFR-mutant lung cancer treatment
Pharmacogenomics,Volume 20, Issue 18, Page 1255-1257, December 2019. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 1, 2019 Category: Genetics & Stem Cells Authors: Marzia Del Re Alfredo Addeo Antonio Passaro Iacopo Petrini Ron HN van Schaik Romano Danesi Source Type: research

CYP2D6*10 pharmacogenetic-guided SERM could be a cost-effective strategy in Chinese patients with hormone receptor-positive breast cancer
Pharmacogenomics, Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - November 26, 2019 Category: Genetics & Stem Cells Authors: Xiaoxia Wei Jiaqin Cai Jie Zhuang Bin Zheng Yuxia Sui Guifeng Zhang Ying Lin Hong Sun Source Type: research

Stakeholder perspectives of the clinical utility of pharmacogenomic testing in solid organ transplantation
Pharmacogenomics, Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - November 23, 2019 Category: Genetics & Stem Cells Authors: Kimberly M Deininger Jacinda N Tran Shirley M Tsunoda Gordon K Young Yee Ming Lee Heather D Anderson Robert L Page II Jan D Hirsch Christina L Aquilante Source Type: research

NAT2 slow acetylator is associated with anti-tuberculosis drug-induced liver injury severity in indonesian population
Pharmacogenomics, Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - November 8, 2019 Category: Genetics & Stem Cells Authors: Rika Yuliwulandari Kinasih Prayuni Retno Wilujeng Susilowati Subagyo Soedarsono Abdul Salam M Sofro Katsushi Tokunaga Jae-Gook Shin Source Type: research

Cell-free DNA and the monitoring of lymphoma treatment
Pharmacogenomics, Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - November 8, 2019 Category: Genetics & Stem Cells Authors: Vincent Camus Fabrice Jardin Source Type: research

Combination of germline variations associated with survival of folinic acid, fluorouracil and irinotecan-treated metastatic colorectal cancer patients
Pharmacogenomics, Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - November 8, 2019 Category: Genetics & Stem Cells Authors: Adrien Labriet Éric Lévesque Elena De Mattia Erika Cecchin Derek Jonker F élix Couture David Simonyan Angela Buonadonna Mario D ’Andrea Lyne Villeneuve Giuseppe Toffoli Chantal Guillemette Source Type: research

Circulating biomarkers of response to immunotherapy in cancer treatment
Pharmacogenomics, Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - November 6, 2019 Category: Genetics & Stem Cells Authors: Marzia Del Re Giulia Gianfilippo Stefania Crucitta Alfredo Addeo Ron HN van Schaik Romano Danesi Source Type: research

DNA repair capacity and response to treatment of colon cancer
Pharmacogenomics, Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - November 6, 2019 Category: Genetics & Stem Cells Authors: Pavel Vodicka Sona Vodenkova Tomas Buchler Ludmila Vodickova Source Type: research

Putative role of pharmacogenetics to elucidate the mechanism of tardive dyskinesia in schizophrenia
Pharmacogenomics, Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - November 5, 2019 Category: Genetics & Stem Cells Authors: Anton JM Loonen Bob Wilffert Svetlana A Ivanova Source Type: research

Severe and prolonged cyclophosphamide-induced hepatotoxicity in a breast cancer patient carrying a CYP2B6*7 variant
Pharmacogenomics, Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - November 5, 2019 Category: Genetics & Stem Cells Authors: Zhao Ming Zhang Yongqiang Zhang Zijin Xu Yan Chen Di Tian Xiaoxin Source Type: research

Genes identified through genome-wide association studies of osteonecrosis in childhood acute lymphoblastic leukemia patients
Pharmacogenomics, Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - November 5, 2019 Category: Genetics & Stem Cells Authors: Vincent Gagn é Anne Aubry-Morin Maria Plesa Rachid Abaji Kateryna Petrykey Pascal St-Onge Patrick Beaulieu Caroline Laverdi ère Nathalie Alos Jean-Marie Leclerc Stephen E Sallan Donna Neuberg Jeffery L Kutok Lewis B Silverman Daniel Sinnett Maja Krajino Source Type: research

Pharmacogenomics in the clinic: genetic polymorphism contributing to venlafaxine-associated heart failure
Pharmacogenomics,Volume 20, Issue 17, Page 1175-1178, November 2019. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - November 1, 2019 Category: Genetics & Stem Cells Authors: Harleen Singh Barent DuBois Zain Al-Jammali Thomas Barrett Source Type: research

Targeting DNA methylation for treating triple-negative breast cancer
Pharmacogenomics,Volume 20, Issue 16, Page 1151-1157, November 2019. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - November 1, 2019 Category: Genetics & Stem Cells Authors: Jia Yu Jacqueline Zayas Bo Qin Liewei Wang Source Type: research

The effects of rosiglitazone on the neonatal rat cardiomyocyte transcriptome: a temporal analysis
Pharmacogenomics,Volume 20, Issue 16, Page 1125-1141, November 2019. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - November 1, 2019 Category: Genetics & Stem Cells Authors: Willian Abraham da Silveira Esteban Vazquez-Hidalgo Elesha Bartolotta Ludivine Renaud Paul Paolini Gary Hardiman Source Type: research

Pharmacogenomics of anticoagulation therapy: the last 10  years
Pharmacogenomics,Volume 20, Issue 16, Page 1113-1117, November 2019. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - November 1, 2019 Category: Genetics & Stem Cells Authors: Georgia Ragia Vangelis G Manolopoulos Source Type: research

Methotrexate pharmacogenetics in the treatment of rheumatoid arthritis
Pharmacogenomics, Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - October 25, 2019 Category: Genetics & Stem Cells Authors: Jekic Biljana Maksimovic Nela Damnjanovic Tatjana Source Type: research

The future of pharmacogenetics in the treatment of migraine
Pharmacogenomics, Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - October 22, 2019 Category: Genetics & Stem Cells Authors: Marina Borro Martina Guglielmetti Maurizio Simmaco Paolo Martelletti Giovanna Gentile Source Type: research

Activation of HCAR2 by niacin: benefits beyond lipid lowering
Pharmacogenomics, Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - October 16, 2019 Category: Genetics & Stem Cells Authors: Sony Tuteja Source Type: research

Use of circulating tumoral DNA to guide treatment for metastatic melanoma
Pharmacogenomics, Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - October 9, 2019 Category: Genetics & Stem Cells Authors: Guillaume Herbreteau Sandrine Charpentier Audrey Vall ée Marc G Denis Source Type: research

A stepwise approach to implementing pharmacogenetic testing in the primary care setting
Pharmacogenomics,Volume 20, Issue 15, Page 1103-1112, October 2019. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - October 7, 2019 Category: Genetics & Stem Cells Authors: Kristin Wiisanen Weitzel Benjamin Q Duong Meghan J Arwood Aniwaa Owusu-Obeng Noura S Abul-Husn Barbara A Bernhardt Brian Decker Joshua C Denny Eric Dietrich John Gums Ebony B Madden Toni I Pollin Rebekah Ryanne Wu Susanne B Haga Carol R Horowitz Source Type: research

Pharmacogenetics and the treatment of epilepsy: what do we know?
Pharmacogenomics,Volume 20, Issue 15, Page 1093-1101, October 2019. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - October 7, 2019 Category: Genetics & Stem Cells Authors: Nada Bo žina Ivana Šušak Sporiš Tamara Bo žina Iva Klarica-Domjanovi ć Ante Tvrdei ć Davor Spori š Source Type: research

CYP3A5 is unlikely to mediate anticancer drug resistance in hepatocellular carcinoma
Pharmacogenomics,Volume 20, Issue 15, Page 1085-1092, October 2019. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - October 7, 2019 Category: Genetics & Stem Cells Authors: Volker M Lauschke Åsa Nordling Yitian Zhou Sara Fontalva Isabel Barragan Magnus Ingelman-Sundberg Source Type: research

Impact of CYP3A4/5 and ABCB1 polymorphisms on tacrolimus exposure and response in pediatric primary nephrotic syndrome
Pharmacogenomics,Volume 20, Issue 15, Page 1071-1083, October 2019. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - October 7, 2019 Category: Genetics & Stem Cells Authors: Lingfei Huang Junyan Wang Jufei Yang Huifen Zhang Yinghua Ni Zhengyi Zhu Huijuan Wang Peng Gao Yuanyuan Wu Jianhua Mao Luo Fang Source Type: research

4th ESPT Conference: pharmacogenomics and personalized medicine  – research progress and clinical implementation
Pharmacogenomics,Volume 20, Issue 15, Page 1063-1069, October 2019. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - October 7, 2019 Category: Genetics & Stem Cells Authors: Csilla Sipeky Adri án Llerena Vangelis G Manolopoulos Ewan Pearson Vid Mlakar Lucia Gozzo Maurizio Simmaco Paolo Marchetti Marzia Del Re Sanja Stankovic Urs Meyer Ingolf Cascorbi Magnus Ingelman-Sundberg Guilherme Suarez-Kurtz Janja Marc Theodora Katsila Source Type: research